Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins

被引:12
|
作者
Buonamassa, DT
Greer, CE
Capo, S
Yen, TSB
Galeotti, CL
Bensi, G
机构
[1] Chiron SpA, IRIS, Dept Mol Biol, I-53100 Siena, Italy
[2] Chiron Corp, Vaccine Res, Emeryville, CA 94608 USA
[3] Vet Adm Med Ctr, Dept Pathol, San Francisco, CA 94121 USA
[4] Univ Calif San Francisco, San Francisco, CA 94121 USA
关键词
papillomavirus; capsid proteins; VLP assembly; yeast expression;
D O I
10.1006/viro.2001.1289
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The L1 and L2 capsid proteins of animal and human papillomaviruses (HPVs) can self-assemble into virus-like particles (VLPs) that closely resemble native virions. The use of different animal models shows that VLPs can be very efficient at inducing a protective immune response. However, studies with infectious HPV virions and VLPs of different HPV types indicate that the immune response is predominantly type-specific. We have generated a diploid yeast strain that coexpresses the L1 and L2 capsid proteins of both HPV-6b and HPV-16, and we have purified fully assembled VLPs banding in a cesium chloride gradient at the expected density of 1.29-1.3 mg/ml. Experimental evidence strongly indicated that the four proteins coassembled into VLPs. Western blot analysis, using anti-HPV-6 and anti-HPV-16 L1-specific monoclonal antibodies and type-specific L2 antisera, demonstrated that all four proteins copurified, Most importantly, immunoprecipitation experiments, carried out using type-specific anti-L1 monoclonals and either total yeast cell extracts or purified VLPs, confirmed the interaction and the formation of covalent disulfide bonds between the two L1 proteins. Finally, HPV-6/16 VLPs administered to mice induced conformational antibodies against both L1 protein types. These results suggest that coexpression of different capsid proteins may provide new tools for the induction of antibodies directed against multiple HPV types. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:335 / 344
页数:10
相关论文
共 50 条
  • [31] A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer
    Borysiewicz, LK
    Fiander, A
    Nimako, M
    Man, S
    Wilkinson, GWG
    Westmoreland, D
    Evans, AS
    Adams, M
    Stacey, SN
    Boursnell, MEG
    Rutherford, E
    Hickling, JK
    Inglis, SC
    LANCET, 1996, 347 (9014): : 1523 - 1527
  • [32] BACULOVIRUS EXPRESSION OF THE HUMAN PAPILLOMAVIRUS TYPE-16 CAPSID PROTEINS - DETECTION OF L1-L2 PROTEIN COMPLEXES
    XI, SZ
    BANKS, LM
    JOURNAL OF GENERAL VIROLOGY, 1991, 72 : 2981 - 2988
  • [33] Human papillomavirus type 16 capsid proteins produced from recombinant Semliki forest virus assemble into virus-like particles
    Heino, P
    Dillner, J
    Schwartz, S
    VIROLOGY, 1995, 214 (02) : 349 - 359
  • [34] Simultaneous quantification of major capsid protein of human papillomavirus 16 and human papillomavirus 18 in multivalent human papillomavirus vaccines by liquid chromatography-tandem mass spectrometry
    Ning, Tingting
    Sun, Shanshan
    Nie, Jianhui
    li, Mengyi
    Huang, Weijin
    Li, Xuguang
    Cao, Jin
    Wang, Youchun
    Journal of Chromatography A, 2021, 1619
  • [35] Simultaneous quantification of major capsid protein of human papillomavirus 16 and human papillomavirus 18 in multivalent human papillomavirus vaccines by liquid chromatography-tandem mass spectrometry
    Ning, Tingting
    Sun, Shanshan
    Nie, Jianhui
    Li, Mengyi
    Huang, Weijin
    Li, Xuguang
    Cao, Jin
    Wang, Youchun
    JOURNAL OF CHROMATOGRAPHY A, 2020, 1619
  • [36] Human Papillomavirus L1 Capsid Protein and Human Papillomavirus Type 16 as Prognostic Markers in Cervical Intraepithelial Neoplasia 1
    Choi, Young Sam
    Kang, Woo Dae
    Kim, Seok Mo
    Choi, Yoo Duk
    Nam, Jong Hee
    Park, Chang Soo
    Choi, Ho Sun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (02) : 288 - 293
  • [37] HUMAN PAPILLOMAVIRUS-6, PAPILLOMAVIRUS-11, AND PAPILLOMAVIRUS-16 IN LARYNGEAL PAPILLOMAS
    DICKENS, P
    SRIVASTAVA, G
    LOKE, SL
    LARKIN, S
    JOURNAL OF PATHOLOGY, 1991, 165 (03): : 243 - 246
  • [38] Polymorphism of the Capsid L1 Gene of Human Papillomavirus Types 31, 33, and 35
    Cornut, Gilbert
    Gagnon, Simon
    Hankins, Catherine
    Money, Deborah
    Pourreaux, Karina
    Franco, Eduardo L.
    Coutlee, Francois
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (07) : 1168 - 1178
  • [39] Sexual behavior and infection with cervical human papillomavirus types 16 and 18
    Itarat, Yuwadee
    Kietpeerakool, Chumnan
    Jampathong, Nampet
    Chumworathayi, Bandit
    Kleebkaow, Pilaiwan
    Aue-aungkul, Apiwat
    Nhokaew, Wilasinee
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2019, 11 : 489 - 494
  • [40] A safe and effective vaccine against human papillomavirus types 16 and 18
    Nature Clinical Practice Oncology, 2006, 3 (7): : 348 - 348